Upgrade to SI Premium - Free Trial

Ocular Therapeutix (OCUL)

8.59 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/10/26)

Latest Headlines

Ocular Therapeutix (OCUL) Reiterated at Market Outperform by Citizens Ahead of Q2 Earnings July 17, 2026 5:17 AM - StreetInsider Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) July 9, 2026 4:05 PM - Globe NewsWire Ocular Therapeutix™ to Participate in July Scientific and Investor Conferences July 1, 2026 7:00 AM - Globe NewsWire William Blair Adjusts Monthly Analyst Conviction List for July 2026 July 1, 2026 6:19 AM - StreetInsider Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) June 22, 2026 4:05 PM - Globe NewsWire Ocular Therapeutix (OCUL) PT Raised to $25 at H.C. Wainwright June 22, 2026 6:59 AM - StreetInsider Form 4 OCULAR THERAPEUTIX, INC For: Jun 16 Filed by: Dugel Pravin June 18, 2026 4:01 PM - SEC Filing Ocular Therapeutix (OCUL) PT Raised to $30 at Baird June 18, 2026 6:14 AM - StreetInsider Ocular Therapeutix plans wet AMD drug filing for late 2026 June 17, 2026 8:45 AM - StreetInsider Ocular Therapeutix™ Investor Day to Highlight U.S. FDA Alignment on AXPAXLI™ NDA with Submission Planned for Fourth Quarter 2026 June 17, 2026 8:45 AM - Globe NewsWire Ocular Therapeutix (OCUL) Halted, News Pending June 17, 2026 8:41 AM - StreetInsider Form 4 OCULAR THERAPEUTIX, INC For: Jun 10 Filed by: Warden Charles M June 12, 2026 5:23 PM - SEC Filing Form 4 OCULAR THERAPEUTIX, INC For: Jun 10 Filed by: Graves Adrienne L June 12, 2026 5:23 PM - SEC Filing Form 4 OCULAR THERAPEUTIX, INC For: Jun 10 Filed by: Robins Jason Shand June 12, 2026 5:22 PM - SEC Filing Form 4 OCULAR THERAPEUTIX, INC For: Jun 10 Filed by: Hong Seung Suh June 12, 2026 5:21 PM - SEC Filing Form 4 OCULAR THERAPEUTIX, INC For: Jun 10 Filed by: LINDSTROM RICHARD L MD June 12, 2026 5:21 PM - SEC Filing Form 4 OCULAR THERAPEUTIX, INC For: Jun 10 Filed by: RAINES MERILEE June 12, 2026 5:20 PM - SEC Filing Form 4 OCULAR THERAPEUTIX, INC For: Jun 10 Filed by: Williams Leslie J. June 12, 2026 5:19 PM - SEC Filing Form 8-K OCULAR THERAPEUTIX, INC For: Jun 10 June 12, 2026 4:23 PM - SEC Filing Form 4 OCULAR THERAPEUTIX, INC For: Jun 03 Filed by: Waheed Nadia June 5, 2026 4:01 PM - SEC Filing Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) June 5, 2026 7:00 AM - Globe NewsWire Ocular Therapeutix™ to Participate in Clinical Trials at the Summit 2026 June 4, 2026 7:00 AM - Globe NewsWire Form 144 OCULAR THERAPEUTIX, INC Filed by: Waheed Nadia June 3, 2026 4:07 PM - SEC Filing Ocular Therapeutix™ to Host Investor Day on June 17, 2026 June 2, 2026 7:00 AM - Globe NewsWire Form 4 OCULAR THERAPEUTIX, INC For: May 26 Filed by: Dugel Pravin May 28, 2026 4:52 PM - SEC Filing Form 4 OCULAR THERAPEUTIX, INC For: May 26 Filed by: Kaiser Peter May 28, 2026 4:51 PM - SEC Filing Form 4 OCULAR THERAPEUTIX, INC For: May 26 Filed by: Heier Jeffrey S. May 28, 2026 4:51 PM - SEC Filing Form 4 OCULAR THERAPEUTIX, INC For: May 26 Filed by: Nayak Sanjay May 28, 2026 4:50 PM - SEC Filing Form 144 OCULAR THERAPEUTIX, INC Filed by: Nayak Sanjay May 26, 2026 4:41 PM - SEC Filing Form 144 OCULAR THERAPEUTIX, INC Filed by: Kaiser Peter May 26, 2026 4:41 PM - SEC Filing Form 144 OCULAR THERAPEUTIX, INC Filed by: Heier Jeffrey S. May 26, 2026 4:40 PM - SEC Filing Form 144 OCULAR THERAPEUTIX, INC Filed by: Dugel Pravin May 26, 2026 4:38 PM - SEC Filing Form SCHEDULE 13G/A OCULAR THERAPEUTIX, INC Filed by: Deep Track Capital, LP May 15, 2026 8:46 AM - SEC Filing Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) May 15, 2026 7:00 AM - Globe NewsWire Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) May 8, 2026 4:05 PM - Globe NewsWire Form 10-Q OCULAR THERAPEUTIX, INC For: Mar 31 May 5, 2026 7:29 AM - SEC Filing Ocular Therapeutix (OCUL) Misses Q1 EPS by 9c May 5, 2026 7:22 AM - StreetInsider Form 8-K OCULAR THERAPEUTIX, INC For: May 05 May 5, 2026 7:07 AM - SEC Filing Ocular Therapeutix™ Reports First Quarter 2026 Financial Results and Business Highlights May 5, 2026 7:00 AM - Globe NewsWire Form DEFA14A OCULAR THERAPEUTIX, INC April 30, 2026 5:25 PM - SEC Filing Form DEF 14A OCULAR THERAPEUTIX, INC For: Jun 11 April 30, 2026 5:18 PM - SEC Filing Form ARS OCULAR THERAPEUTIX, INC For: Dec 31 April 30, 2026 4:40 PM - SEC Filing H.C. Wainwright Reiterates Buy Rating on Ocular Therapeutix (OCUL) April 30, 2026 6:54 AM - StreetInsider Ocular Therapeutix enrolls first patient in SOL-X extension trial April 29, 2026 7:00 AM - StreetInsider Ocular Therapeutix™ Announces First Patient Enrolled in SOL-X Long-Term Extension Trial for AXPAXLI™ in Wet AMD April 29, 2026 7:00 AM - Globe NewsWire Ocular Therapeutix™ to Report First Quarter 2026 Financial Results on May 5, 2026 April 28, 2026 7:00 AM - Globe NewsWire Ocular Therapeutix™ to Participate in May Scientific and Investor Conferences April 27, 2026 7:00 AM - Globe NewsWire Full Article List